Cargando…

Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis

BACKGROUND: Statins have been recommended for the use in atherosclerotic cardiovascular diseases, but different statins have distinct pharmacological characteristics. This multi-treatment meta-analysis aimed to evaluate the efficacy of seven statins in the secondary prevention of major cerebrovascul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Ping, Wu, Danhong, Ye, Xiaofei, Wu, Ying, Li, Tuming, Tong, Shuwen, Liu, Xueyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587089/ https://www.ncbi.nlm.nih.gov/pubmed/28919704 http://dx.doi.org/10.2147/DDDT.S135785

Ejemplares similares

Efficacy of Standard and Intensive Statin Treatment for the Secondary Prevention of Cardiovascular and Cerebrovascular Events in Diabetes Patients: A Meta-Analysis
por: de Vries, Folgerdiena M., et al.
Publicado: (2014)

Cerebrovascular Disease and Statins
por: Beltrán Romero, Luis M., et al.
Publicado: (2021)

Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases
por: Wei, Zhenyu, et al.
Publicado: (2018)

Risk factors for drug-treated major adverse cardio-cerebrovascular events in patients on primary preventive statin therapy: A retrospective cohort study
por: Steenhuis, Dennis, et al.
Publicado: (2023)

Comparing different types of statins for secondary prevention of cardio-cerebrovascular disease from a national cohort study
por: Kim, Joungyoun, et al.
Publicado: (2021)

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
por: De Luca, Leonardo, et al.
Publicado: (2021)

Impact of statin intensity on adverse cardiac and cerebrovascular events in older adult patients with myocardial infarction
por: Moon, In Tae, et al.
Publicado: (2021)

Does Statin Therapy Reduce the Risks of Mortality and Major Adverse Cardiac and Cerebrovascular Events in Young Adults with End-Stage Renal Disease? Population-Based Cohort Study
por: Cheng, Ya-Lien, et al.
Publicado: (2021)

Persistent hyperglycemia is a useful glycemic pattern to predict stroke mortality: a systematic review and meta-analysis
por: Hou, Duanlu, et al.
Publicado: (2021)

Antioxidant Effects of Statins in Patients with Atherosclerotic Cerebrovascular Disease
por: Moon, Gyeong Joon, et al.
Publicado: (2014)

Effects of a Secondary Prevention Combination Therapy with beta-Blocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients
por: Zhu, Ling, et al.
Publicado: (2020)

Human Urinary kallidinogenase promotes good recovery in ischemic stroke patients with level 3 hypertension
por: Wu, Danhong, et al.
Publicado: (2017)

Persistent inflammation worsens short-term outcomes in massive stroke patients
por: Hou, Duanlu, et al.
Publicado: (2021)

Oxidative Stress: A Major Player in Cerebrovascular Alterations Associated to Neurodegenerative Events
por: Carvalho, Cristina, et al.
Publicado: (2018)

Association of lymphocyte-to-monocyte ratio with in-hospital and long-term major adverse cardiac and cerebrovascular events in patients with ST-elevated myocardial infarction
por: Wang, Qian, et al.
Publicado: (2017)

Elevated SIRT2 of serum exosomes is positively correlated with diagnosis of acute ischemic stroke patients
por: Lu, Wenmei, et al.
Publicado: (2023)

Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
por: Morofuji, Yoichi, et al.
Publicado: (2022)

Underuse of statins for secondary prevention of atherosclerotic cardiovascular disease events among ambulatory surgical patients
por: Schonberger, Robert B., et al.
Publicado: (2020)

Secondary Cerebrovascular Prevention in Light of the COVID-19 Pandemic
por: Padlina, G, et al.
Publicado: (2020)

Prevalence and trends of perioperative major adverse cardiovascular and cerebrovascular events during cancer surgeries
por: Ramamoorthy, Venkataraghavan, et al.
Publicado: (2023)

Safety analysis over time: seven major changes to adverse event investigation
por: Vincent, Charles, et al.
Publicado: (2017)

Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome
por: Baluja, Aurora, et al.
Publicado: (2019)

Major Adverse Cardiac and Cerebrovascular Events in Patients Undergoing Simultaneous Heart Surgery and Carotid Endarterectomy
por: Gerfer, Stephen, et al.
Publicado: (2023)

Electrocardiographic abnormalities in acute cerebrovascular events
por: Wiwanitkit, Somsri, et al.
Publicado: (2013)

Flavivirus Infection Associated with Cerebrovascular Events
por: Estofolete, Cássia F., et al.
Publicado: (2020)

Preconditioning by Preceding Ischemic Cerebrovascular Events
por: Correia, Pamela N., et al.
Publicado: (2021)

Low TLR7 gene expression in atherosclerotic plaques is associated with major adverse cardio- and cerebrovascular events
por: Karadimou, Glykeria, et al.
Publicado: (2017)

Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke
por: Tu, Wen-Jun, et al.
Publicado: (2020)

Identification of potentially inappropriate medications with risk of major adverse cardio- and cerebrovascular events among elderly patients
por: Lima, Joana C. F., et al.
Publicado: (2021)

Long‐Term Blood Pressure Variability and Major Adverse Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage
por: Castello, Juan Pablo, et al.
Publicado: (2022)

Major Adverse Cardiac and Cerebrovascular Events in Geriatric Patients with Obstructive Sleep Apnea: An Inpatient Sample Analysis
por: Desai, Rupak, et al.
Publicado: (2023)

Impact of Plasma Exposure of Statins and Their Metabolites With Major Adverse Cardiovascular Events in Chinese Patients With Coronary Artery Disease
por: Zhou, Xiao-hong, et al.
Publicado: (2020)

Cerebrovascular events after cardiovascular surgery: diagnosis, management and prevention strategies
por: Ferrante, Maria Sabrina, et al.
Publicado: (2023)

Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design
por: Gu, Hong-Qiu, et al.
Publicado: (2020)

Creation and Validation of an EMR-based Algorithm for Identifying Major Adverse Cardiac Events while on Statins
por: Wei, Wei-Qi, et al.
Publicado: (2014)

Preventing Ischemic Cerebrovascular Events in High-Risk Patients With Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning: A Single-Arm Study
por: Liu, Shimeng, et al.
Publicado: (2021)

Inflammation of carotid plaques and risk of cerebrovascular events
por: Poredos, Pavel, et al.
Publicado: (2020)

Atrial Fibrillation as a Risk Factor for Major Adverse Cardiac and Cerebrovascular Events after Non-cardiac Surgery
por: Shin, Dong Geum, et al.
Publicado: (2020)

Development and Validation of a Nomogram of In-hospital Major Adverse Cardiovascular and Cerebrovascular Events in Patients With Acute Coronary Syndrome
por: Bo, Xiangwei, et al.
Publicado: (2021)

Associations of Warfarin Use with Risks of Ischemic Cerebrovascular Events and Major Bleeding in Patients with Hyperthyroidism-Related Atrial Fibrillation
por: Liu, Sian-De, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v9mneu26ggccftn6o2fq52jhul